SCHEMBL9877597

SCHEMBL9877597

CN(O)C(=O)C=Cc1ccc(OCc2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.68
▸ BACE1 P56817 4/20 0.68
▸ MAOB P27338 2/20 0.62
▸ ABCG2 Q9UNQ0 1/20 0.61
▸ ALOX5 P09917 1/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ SLC5A1 P13866 1/20 0.58
▸ SLC5A2 P31639 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ APP P05067 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8320471 0.86 GSK3B (0.52) GSK3BBACE1MAOBABCG2ALOX5
SCHEMBL9344837 0.83 GSK3B (0.76) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL9344834 0.83 GSK3B (0.76) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL7999153 0.83 GSK3B (0.83) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL527828 0.83 GSK3B (0.80) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL527827 0.83 GSK3B (0.80) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL8740053 0.83 GSK3B (0.80) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL7999149 0.83 GSK3B (0.83) GSK3BBACE1MAOBABCG2NPC1
Hydrochloric Acid SCHEMBL7054738 0.81 GSK3B (0.78) GSK3BBACE1MAOBABCG2NPC1
SCHEMBL9735221 0.81 BACE1 (0.81) GSK3BBACE1MAOBABCG2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5036157-A Hydroxamic acid derivatives, lipoxygenase and cyclooxygenase inhibitors, anticoagulants, antiinflammatory agents BURROUGHS WELLCOME CO. 1991-07-30 — — US disclosed
US-4977188-A Hydroamic acid derivatives BURROUGHS WELLCOME CO. (US) 1990-12-11 — — US disclosed
WO-1990001929-A1 NEW MEDICAL USE THE WELLCOME FOUNDATION LIMITED (GB) 1990-03-08 — — WO disclosed
US-4738986-A CYCLOOXYGENASE, LIDOXYGENASE INHIBITORS BURROUGHS WELLCOME CO. (US) 1988-04-19 — — US disclosed
EP-0196184-A2 Aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1986-10-01 — — EP disclosed
Send feedback